Rethinking the Cold Supply Chain

Jan 4, 2018

Healthcare manufacturers should continually look for ways to optimise their cold-chain packaging. In her article, Susan Li of UPS shows that the benefits of doing so can be far-reaching, starting with increased efficiencies and cost savings and extending to safer transportation of pharmaceutical goods and medical devices that improve the quality of lives. ...

Read More

What Clinical Teams Should Know about Changing Trial Logistics and How they will Affect Development – PART 2

Jan 4, 2018

As we shift to what has been described as “an Amazonlike culture”, sponsors want the same opportunity to track shipments in real time and to obtain real-time data that they can analyse. In her paper, Jennifer Worsfold, of Fisher Clinical Services, explains that this has led to a growing focus on new technology, including downloadable temperature monitors, and the ability to access real-time updates on the location and temperature condition of supply shipments. ...

Read More

Strategies for Developing a Cost-Efficient Pharmaceutical Manufacturing Process

Jan 4, 2018

In their paper, Valdas Jurkauskas and Xiaoyong Fu of STA Pharmaceuticals address the fact that manufacturing process throughput optimisation has become a necessity rather than an option. Only having high product yield, volumetrically efficient process and shortest possible production cycle time will enable the sponsor to withstand future increase in labour and utilities costs and reduce the probability of complex, expensive and risky post-approval changes. ...

Read More

Inspecting on the Edge – Understanding Punch Tip Wear

Jan 4, 2018

Punch tip edge wear can come from a variety of circumstances and may cause significant production quality-related issues. In their article, Bill Turner and Kevin Queensen of Natoli look into the common causes of punch tip wear and how to prevent it. Even though it can be difficult to detect because traditional methods of inspection are ineffective, we learn that fortunately, the use of a horizontal optical comparator makes the inspection job easy – and fast. ...

Read More

What Does the Falsified Medicines Directive (FMD) Mean for SMEs and CMOs; and More Importantly, Are These Organisations Ready?

Jan 4, 2018

The implications of the directive are far-reaching and affect all pharmaceutical manufacturers, regardless of size. As time runs out and the deadline grows ever closer, Christian Taylor of Zetes explains in his article how CMOs and SME pharmaceutical manufacturers can ensure they are compliant. If smaller organisations embrace the regulatory changes – using them as an opportunity to optimise their supply chains, they can create true business value, making it pay to be compliant. ...

Read More